LIMN - Latest News

Liminatus Pharma, Inc. Class A Common Stock (LIMN), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $5.7M. Beta to the broader market is 0.74.

The article list below shows the most recent LIMN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent LIMN Headlines

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

globenewswire.com - Aug 24, 2026

FULLERTON, Calif. , Aug.

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

globenewswire.com - Aug 18, 2026

FULLERTON, Calif. , Aug.

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

globenewswire.com - Aug 13, 2026

FULLERTON, Calif. , Aug.

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

globenewswire.com - Jun 30, 2026

FULLERTON, Calif. , June 30, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc.

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

globenewswire.com - Jun 3, 2026

FULLERTON, Calif. , June 03, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc.

How News Affects LIMN Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LIMN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked LIMN news questions

What is the latest LIMN news headline?
The most recent LIMN headline (Aug 24, 2026) is "Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the LIMN news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What LIMN news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual LIMN options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.